BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 5851172)

  • 1. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution to the therapy of juvenile and arteriosclerotic chronic peripheral obliterating artery diseases with a new sympatholytic drug].
    Stoppani L; Lo Cuoco A
    Minerva Cardioangiol; 1966 Mar; 14(3):163-5. PubMed ID: 5937431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral arterial disease--in the field of internal medicine].
    Seki K
    Nihon Rinsho; 1970 Mar; 28 Suppl():854-5. PubMed ID: 5430911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

  • 7. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G; Bagliani A; Borri P
    Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
    [No Abstract]   [Full Text] [Related]  

  • 10. [New data on the use of halidor in obliterative diseases of arteries of the extremities].
    Zolotarevskiĭ VIa; Taranovich VA; Maksimova TV
    Klin Med (Mosk); 1969 Feb; 47(2):67-71. PubMed ID: 5379263
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 12. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of thrombo-obliterative diseases of the lower extremity arteries using acetylcholine].
    Moskalenko VS
    Klin Khir (1962); 1972 May; 5():71-2. PubMed ID: 5043908
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandins in therapy of cardiovascular disease.
    Szczeklik A; Gryglewski RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():345-54. PubMed ID: 3159222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intra-arterial treatment of arterial obliterative disease (author's transl)].
    Mörl H
    Dtsch Med Wochenschr; 1974 Nov; 99(45):2284-6. PubMed ID: 4448136
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M; Perzanowski A; Myśliwiec M
    Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
    [No Abstract]   [Full Text] [Related]  

  • 18. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 19. [Application of bencyclane in arterial insufficiency of the lower limbs].
    Krylov VS; Zuravlev IV; Djacenko GM; Vychovskaja AA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1433+. PubMed ID: 5536664
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intra-arterial infusion therapy of patients with the ischemic syndrome in thrombo-obliterating diseases of the lower extremities in ambulatory conditions].
    Savel'ev IuS
    Vestn Khir Im I I Grek; 1990 Sep; 145(9):131-4. PubMed ID: 1962927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.